Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
about
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemiaReview of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patientsPhase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia.Waldenstrom macroglobulinemiaNew Therapeutic Approaches for Waldenstrom MacroglobulinemiaWaldenstrom macroglobulinemia: prognosis and management.Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.Current and future therapeutic approach for Waldenström's macroglobulinemia.Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
P2860
Q24634360-BB75B402-F9FE-496B-98A4-36784F85871AQ28291793-BA2C8F74-38EA-4C46-98B5-4816C01D69D5Q33394689-A8BF3B99-699C-41C2-961F-457635794F99Q33414529-F566BFC2-0A03-47DA-A1AF-14C787B1844CQ33417803-165F6F8C-7C9E-4C98-9FE1-11384A8654F1Q33711127-EB82021F-A8C3-45DE-A2A1-3FA7A1CC7167Q35097328-E0BE1129-4971-4832-BE7A-BAC616582357Q35176177-451AE4F3-D73D-4108-A288-87A1CC892D87Q35244911-0CC2CD69-A005-459E-A1B5-48095EE82B88Q36341861-73FCB91D-E41F-4C0A-8364-4802E13E6BAEQ36542990-67509C2A-FFEC-4EF0-93F1-074F9998EBC1Q38059720-91358343-E2B7-4715-9065-C5C6C071A3C9Q38206820-076455C7-CDA4-4F6E-BF9E-3ACC64146C07Q38763837-F93EDC9F-1726-4A9B-8B23-39963A1F3518Q39044362-27B9C2C3-9B0F-4FB8-9B33-42BDD0E70E8DQ39738249-55EF80C0-9513-4611-A2DF-3B9EDBFDE1C3Q40329298-E2B9F588-8B4C-4827-807F-CDA41BEA6F9AQ46351985-429ECAB5-5277-4EAA-8364-38D2CE781AE4Q46668187-6D6E9C68-F6A6-4F00-854A-9FF670CC1139Q48204084-D05CE919-898A-4DDF-AF15-B5E892DFC96DQ53288027-78D38ACE-8924-4D25-BBD0-E9DBBC9E3CFA
P2860
Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@ast
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@en
type
label
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@ast
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@en
prefLabel
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@ast
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@en
P2093
P356
P1433
P1476
Uniform response criteria in W ...... ldenstrom's Macroglobulinemia.
@en
P2093
Andrew R Branagan
Christos Emmanouilides
Donna Weber
Joan Bladé
John C Byrd
Steven P Treon
P304
P356
10.1053/SONC.2003.50037
P577
2003-04-01T00:00:00Z